CoChat

Gender, Obesity and Repeated Elevation of C-Reactive Protein: Data from the CARDIA Cohort

Open access
Ishii, Shinya, Karlamangla, Arun S., Bote, Marcos, Irwin, Michael R., Jacobs, David R., Cho, Hyong Jin, Seeman, Teresa E. · 2012 · PLoS ONE
Cited by 107

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

C-reactive Protein (CRP) measurements above 10 mg/L have been conventionally treated as acute inflammation and excluded from epidemiologic studies of chronic inflammation. However, recent evidence suggest that such CRP elevations can be seen even with chronic inflammation. The authors assessed 3,300 participants in The Coronary Artery Risk Development in Young Adults study, who had two or more CRP measurements between 1992/3 and 2005/6 to a) investigate characteristics associated with repeated CRP elevation above 10 mg/L; b) identify subgroups at high risk of repeated elevation; and c) investigate the effect of different CRP thresholds on the probability of an elevation being one-time rather than repeated. 225 participants (6.8%) had one-time and 103 (3.1%) had repeated CRP elevation above 10 mg/L. Repeated elevation was associated with obesity, female gender, low income, and sex hormone use. The probability of an elevation above 10 mg/L being one-time rather than repeated was lowest (51%) in women with body mass index above 31 kg/m(2), compared to 82% in others. These findings suggest that CRP elevations above 10 mg/L in obese women are likely to be from chronic rather than acute inflammation, and that CRP thresholds above 10 mg/L may be warranted to distinguish acute from chronic inflammation in obese women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0036062

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 32

  1. GL Myers, 2004, CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group., Circulation, 110, e545, 10.1161/01.CIR.0000148980.87579.5E · DOI · Paper page
  2. PM Ridker, 2004, Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores., Circulation, 109, 1955, 10.1161/01.CIR.0000125690.80303.A8 · DOI · Paper page
  3. DE Alley, 2006, Socioeconomic status and C-reactive protein levels in the US population: NHANES IV., Brain Behav Immun, 20, 498, 10.1016/j.bbi.2005.10.003 · DOI · Paper page
  4. A Nazmi, 2008, Correlates of C-reactive protein levels in young adults: a population-based cohort study of 3827 subjects in Brazil., Braz J Med Biol Res, 41, 357, 10.1590/S0100-879X2008000500003 · DOI · Paper page
  5. M Hamer, 2009, Association of very highly elevated C-reactive protein concentration with cardiovascular events and all-cause mortality., Clin Chem, 56, 132, 10.1373/clinchem.2009.130740 · DOI
  6. KW Muir, 1999, C-reactive protein and outcome after ischemic stroke., Stroke, 30, 981, 10.1161/01.STR.30.5.981 · DOI · Paper page
  7. GR Cutter, 1991, Cardiovascular risk factors in young adults. The CARDIA baseline monograph., Control Clin Trials, 12, 1S, 10.1016/0197-2456(91)90002-4 · DOI · Paper page
  8. GD Friedman, 1988, CARDIA: study design, recruitment, and some characteristics of the examined subjects., J Clin Epidemiol, 41, 1105, 10.1016/0895-4356(88)90080-7 · DOI · Paper page
  9. S Sidney, 1991, Comparison of two methods of assessing physical activity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study., Am J Epidemiol, 133, 1231, 10.1093/oxfordjournals.aje.a115835 · DOI · Paper page
  10. A Khera, 2009, Sex differences in the relationship between C-reactive protein and body fat., J Clin Endocrinol Metab, 94, 3251, 10.1210/jc.2008-2406 · DOI · Paper page
  11. O Chenillot, 2000, High sensitivity C-reactive protein: biological variations and reference limits., Clin Chem Lab Med, 38, 1003, 10.1515/CCLM.2000.149 · DOI
  12. KK Ray, 2005, Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial., J Am Coll Cardiol, 46, 1417, 10.1016/j.jacc.2005.08.024 · DOI
  13. M Groblewska, 2008, Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients., Clin Chem Lab Med, 46, 1423, 10.1515/CCLM.2008.278 · DOI
  14. C Siemes, 2006, C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study., J Clin Oncol, 24, 5216, 10.1200/JCO.2006.07.1381 · DOI · Paper page
  15. K Heikkila, 2007, A systematic review of the association between circulating concentrations of C reactive protein and cancer., J Epidemiol Community Health, 61, 824, 10.1136/jech.2006.051292 · DOI · Paper page
  16. T Hastie, 2009, The Elements of Statistical Learning: Data Mining, Inference, and Prediction., 10.1007/978-0-387-84858-7 · DOI · Paper page
  17. FE Harrell, 2001, Regression Modeling Strategies : With Applications to Linear Models, Logistic Regression, and Survival Analysis., 10.1007/978-1-4757-3462-1 · DOI · Paper page
  18. AJ Izenman, 2008, Modern Multivariate Statistical Techniques : Regression, Classification, Manifold Learning., 10.1007/978-0-387-78189-1 · DOI · Paper page
  19. LA Bazzano, 2003, Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States., Ann Intern Med, 138, 891, 10.7326/0003-4819-138-11-200306030-00010 · DOI · Paper page
  20. JR Greenfield, 2004, Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences., Circulation, 109, 3022, 10.1161/01.CIR.0000130640.77501.79 · DOI · Paper page
  21. AV Chobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report., Jama, 289, 2560, 10.1001/jama.289.19.2560 · DOI · Paper page
  22. JR Rodgers, 1993, Chronic Poverty in the United States., The Journal of Human Resources, 28, 25, 10.2307/146087 · DOI · Paper page
  23. AS Karlamangla, 2005, Impact of socioeconomic status on longitudinal accumulation of cardiovascular risk in young adults: the CARDIA Study (USA)., Soc Sci Med, 60, 999, 10.1016/j.socscimed.2004.06.056 · DOI
  24. S Macintyre, 1997, Socio-economic Position, Gender and Health: How Do They Interact?, J Health Psychol, 2, 315, 10.1177/135910539700200304 · DOI · Paper page
  25. DS Goldstein, 1995, Stress, Catecholamines, and Cardiovascular Disease: Oxford University Press
  26. P Bjorntorp, 2001, Do stress reactions cause abdominal obesity and comorbidities?, Obes Rev, 2, 73, 10.1046/j.1467-789x.2001.00027.x · DOI · Paper page
  27. P Calabro, 2005, Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation., J Am Coll Cardiol, 46, 1112, 10.1016/j.jacc.2005.06.017 · DOI · Paper page
  28. SG Lakoski, 2005, Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial., Am Heart J, 150, 907, 10.1016/j.ahj.2004.11.025 · DOI
  29. P Hu, 2006, The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial., Atherosclerosis, 185, 347, 10.1016/j.atherosclerosis.2005.06.011 · DOI
  30. ME Falagas, 2006, Obesity and infection., Lancet Infect Dis, 6, 438, 10.1016/S1473-3099(06)70523-0 · DOI · Paper page
  31. CE Ruhl, 2004, Serum leptin concentrations and body adipose measures in older black and white adults., Am J Clin Nutr, 80, 576, 10.1093/ajcn/80.3.576 · DOI
  32. A Cartier, 2009, Sex differences in inflammatory markers: what is the contribution of visceral adiposity?, Am J Clin Nutr, 89, 1307, 10.3945/ajcn.2008.27030 · DOI · Paper page

Cited by

See all 107

Metadata

Authors
Ishii, S., Karlamangla, A. S., Bote, M., Irwin, M. R., Jacobs, D. R., Cho, H. J., & Seeman, T. E.
Venue
PLoS ONE
Published
2012-04-30
Volume
7
Issue
4
Pages
e36062
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2044527758
Cited by
107
References
9
FWCI
6.89
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.